MIT-Industry Program Under Siege

CAMBRIDGE, MASS.—Every summer, Eric Johnson plays Santa Claus to deserving faculty at the Massachusetts Institute of Technology. And the list that he checks before he hands out his gifts is laid out in a 3-inch-thick computer printout—an account of “points” accumulated by individual faculty members over the past year as the reward for having met with representatives of private industry to discuss their work and share their technical expertise. Those points are converted

Written byAlan Cooperman
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

CAMBRIDGE, MASS.—Every summer, Eric Johnson plays Santa Claus to deserving faculty at the Massachusetts Institute of Technology. And the list that he checks before he hands out his gifts is laid out in a 3-inch-thick computer printout—an account of “points” accumulated by individual faculty members over the past year as the reward for having met with representatives of private industry to discuss their work and share their technical expertise. Those points are converted into cash that the faculty members can use for such research-related “extras” as lab equipment and professional travel.

Johnson is director of the university’s Industrial Liaison Program (ILP), a 41 -year-old program that charges firms an average of $50,000 for the chance to learn first-hand what is going on in the minds and labs of university scientists. Over the years, the program has won its share of high praise. Suddenly, it has come under fire.

The congressional ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies